#1 Samsung Medical Center
Seoul, South Korea
Samsung Medical Center leads on Site Startup Speed / PI Capacity / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#2 National Taiwan University Hospital
Taipei, Taiwan
National Taiwan University Hospital leads on PI Capacity / Site Startup Speed / Execution Stability, resulting in Tier 3 prioritization for feasibility shortlisting.
#3 Memorial Sloan Kettering Cancer Center
New York, United States
Memorial Sloan Kettering Cancer Center leads on PI Capacity / Execution Stability / TA/Indication Experience, resulting in Tier 3 prioritization for feasibility shortlisting.
#4 Eberhard Karls Universitaet Tuebingen (EKUT)
Tübingen, Germany
Eberhard Karls Universitaet Tuebingen (EKUT) leads on Competitor Exposure / TA/Indication Experience / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#5 Radboud University Medical Center (Radboudumc)
Nijmegen, Netherlands
Radboud University Medical Center (Radboudumc) leads on Competitor Exposure / TA/Indication Experience / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#6 Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
Hospital de la Santa Creu i Sant Pau leads on PI Capacity / TA/Indication Experience / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#7 Washington University School of Medicine - Siteman Cancer Center
St Louis, United States
Washington University School of Medicine - Siteman Cancer Center leads on TA/Indication Experience / PI Capacity / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#8 Korea University Anam Hospital
Seoul, South Korea
Korea University Anam Hospital leads on TA/Indication Experience / PI Capacity / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#9 Institut Jules Bordet
Anderlecht, Belgium
Institut Jules Bordet leads on TA/Indication Experience / PI Capacity / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#10 Kanagawa Cancer Center
Yokohama, Japan
Kanagawa Cancer Center leads on TA/Indication Experience / PI Capacity / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#11 National Cancer Center Hospital
Chuo Ku, Japan
National Cancer Center Hospital leads on TA/Indication Experience / PI Capacity / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#12 Severance Hospital, Yonsei University Health System
Seoul, South Korea
Severance Hospital, Yonsei University Health System leads on TA/Indication Experience / PI Capacity / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#13 Taipei Medical University Hospital
Taipei, Taiwan
Taipei Medical University Hospital leads on TA/Indication Experience / PI Capacity / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#14 National Cheng Kung University Hospital
Tainan, Taiwan
National Cheng Kung University Hospital leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#15 Complejo Hospitalario Universitario A Coruña
A Coruña, Spain
Complejo Hospitalario Universitario A Coruña leads on TA/Indication Experience / PI Capacity / ClinicalTrials.gov Relevance, resulting in Tier 3 prioritization for feasibility shortlisting.
#16 Roswell Park Cancer Institute
Buffalo, United States
Roswell Park Cancer Institute leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#17 Kanazawa University Hospital
Kanazawa, Japan
Kanazawa University Hospital leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#18 Amsterdam UMC, Locatie VUMC
Amsterdam, Netherlands
Amsterdam UMC, Locatie VUMC leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#19 National University Hospital
Singapore, Singapore
National University Hospital leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#20 Hôpital Bichat - Claude Bernard
Paris, France
Hôpital Bichat - Claude Bernard leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#21 Erasmus Medisch Centrum
Rotterdam, Netherlands
Erasmus Medisch Centrum leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#22 Hospital Universitari Dexeus
Barcelona, Spain
Hospital Universitari Dexeus leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#23 Ospedale Santa MAria della Misericordia
Perugia, Italy
Ospedale Santa MAria della Misericordia leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#24 National Cancer Centre Singapore
Singapore, Singapore
National Cancer Centre Singapore leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#25 AZ Groeninge
Kortrijk, Belgium
AZ Groeninge leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#26 Centre Hospitalier Intercommunal de Créteil
Créteil, France
Centre Hospitalier Intercommunal de Créteil leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#27 Kantonsspital St. Gallen
Sankt Gallen, Switzerland
Kantonsspital St. Gallen leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#28 Blacktown Medical Oncology Research
Blacktown, Australia
Blacktown Medical Oncology Research leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#29 Calvary Mater Newcastle
Waratah, Australia
Calvary Mater Newcastle leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#30 Mater Misericordiae Limited
South Brisbane, Australia
Mater Misericordiae Limited leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#31 Grand Hôpital de Charleroi - Les Viviers
Gilly, Belgium
Grand Hôpital de Charleroi - Les Viviers leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#32 Institut de Cancerologie de l Ouest
Saint-Herblain, France
Institut de Cancerologie de l Ouest leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#33 Universitaetsklinikum Essen
Essen, Germany
Universitaetsklinikum Essen leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#34 Hong Kong United Oncology Centre
Hong Kong, Hong Kong
Hong Kong United Oncology Centre leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#35 University Hospital Limerick
Cork, Ireland
University Hospital Limerick leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#36 IEO Istituto Europeo di Oncologia
Milan, Italy
IEO Istituto Europeo di Oncologia leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#37 Azienda Socio Sanitaria Territoriale Niguarda
Milan, Italy
Azienda Socio Sanitaria Territoriale Niguarda leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#38 Med-Polonia Sp. z o.o.
Poznan, Poland
Med-Polonia Sp. z o.o. leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#39 Pan American Center for Oncology Trials
San Juan, Puerto Rico
Pan American Center for Oncology Trials leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#40 Shanghai Pulmonary Hospital
Shanghai, China
Shanghai Pulmonary Hospital leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#41 LKI Lungenfachklinik Immenhausen
Immenhausen, Germany
LKI Lungenfachklinik Immenhausen leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#42 Mater Private Hospital
Dublin, Ireland
Mater Private Hospital leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#43 INSTYTUT GENETYKI I IMMMUNOLOGII GENIM sp. z o.o.
Lublin, Poland
INSTYTUT GENETYKI I IMMMUNOLOGII GENIM sp. z o.o. leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#44 Aidport Sp. z o.o.
Skorzewo, Poland
Aidport Sp. z o.o. leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#45 Universitätsspital Basel
Basel, Switzerland
Universitätsspital Basel leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.
#46 HFR Fribourg/Kantonsspital Fribourg
Fribourg, Switzerland
HFR Fribourg/Kantonsspital Fribourg leads on TA/Indication Experience / ClinicalTrials.gov Relevance / Sponsor Fit, resulting in Tier 3 prioritization for feasibility shortlisting.